# Pharmacokinetics and Pharmacodynamics of TAK-875 in Subjects With Type 2 Diabetes

> **NCT00949091** · PHASE1 · COMPLETED · sponsor: **Takeda** · enrollment: 60 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** TAK-875

## Key facts

- **NCT ID:** NCT00949091
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2009-07
- **Final completion:** 2009-07
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2010-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00949091

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00949091, "Pharmacokinetics and Pharmacodynamics of TAK-875 in Subjects With Type 2 Diabetes". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00949091. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*